NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)
| 1.33 Data as of 3:59pm ET |  -0.01 / -0.75%Today’s Change | 0.90 Today|||52-Week Range 1.76 | +17.70% Year-to-Date |
Latest NBY News | Press Releases
No recent news for NovaBay Pharmaceuticals Inc.
Today’s Trading
| Previous close | 1.34 |
| Today’s open | 1.32 |
| Day’s range | 1.23 - 1.33 |
| Volume | 330,164 |
| Average volume (3 months) | 197,143 |
| Market cap | $50.0M |
| Dividend yield | -- |
Data as of 3:59pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | -20.00% |
| Earnings growth (this year) | -22.22% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -36.95% |
| P/E ratio | NM |
| Price/Sales | 4.79 |
| Price/Book | 3.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BGMDBG Medicine Inc | +0.02 | +1.13% |
| BIODBiodel Inc | +0.06 | +1.66% |
| VTUSVentrus Biosciences ... | +0.09 | +3.37% |
| CYCCCyclacel Pharmaceuti... | +0.19 | +6.35% |
Data as of 4:00pm ET, 05/23/2013
Financials
| Next reporting date | August 15, 2013 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $6.9M |
| Annual profit (last year) | -$7.0M |
| Net profit margin | -101.15% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Ramin Najafi, PhD |
Chief Financial Officer, Secretary & Treasurer Thomas J. Paulson, MBA |
Corporate headquarters Emeryville, California |
Forecasts
